The Association of British Pharmaceutical Industry launched today a new, open and publicly available database listing in detail the transfers of value between pharmaceutical companies and healthcare professionals and organisations.
Professor Sir Robert Lechler, President of the Academy of Medical Sciences welcomed the launch of the ABPI’s initiative, Disclosure UK, and added:
“Successful partnerships between industry, academia and the healthcare sector can speed up the rate of scientific discovery and innovation and they are key to accelerating the translation of research into benefits for society. However, many people are concerned about how these partnerships might compromise the integrity of research.
“That is why it is of the utmost importance that the nature of these collaborations and their impact on research are communicated to the public in a clear and transparent way.
“Disclosure UK is a welcome step towards creating the level of transparency and accountability that the public need to assess the trustworthiness of these partnerships.”